BABA vs DBI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

DBI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational deterioration. While the stock has seen a massive 1-year price surge of 203.8%, this rally is decoupled from fundamentals: revenue growth is stagnant at 0.00%, and the company is operating with negative profit and operating margins. A critical Debt/Equity ratio of 4.30 and a dangerously low Quick Ratio of 0.19 suggest significant liquidity risks. Furthermore, the dividend is unsustainable with a 500% payout ratio, effectively acting as a return of capital rather than a return on earnings.